L(+) and D(-) Lactate Are Increased in Plasma and Urine Samples of Type 2 Diabetes as Measured by a Simultaneous Quantification of L(+) and D(-) Lactate by Reversed-Phase Liquid Chromatography Tandem Mass Spectrometry

Figure 3

Urinary and plasma D- and L-Lactate concentrations of controls, patients with inflammatory bowel disease (IBD), and patients with type 2 diabetic patients (T2DM). Data are presented as Mean ± SEM: (*𝑃<0.05).

(a)

(b)

(c)

(d)